https://www.pharmanow.live/latest-news/cyncado-therapeutics-advances-cancer-treatments
Cyncado Therapeutics Advances Cancer Treatments
Portage Biotech re-launches Cyncado Therapeutics, with CEO Peter Molloy driving the development of adenosine receptor antagonists for cancer.
therapeuticsadvancescancertreatments